Risk factor
Negligible price volatility
Profitability factor
Strong margins and returns
About
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of SFZN.SW is 112 and suggests 34% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell